Literature DB >> 35128676

Role of inhibitory signaling in peripheral B cell tolerance.

Andrew Getahun1,2.   

Abstract

At least 20% of B cells in the periphery expresses an antigen receptor with a degree of self-reactivity. If activated, these autoreactive B cells pose a risk as they can contribute to the development of autoimmune diseases. To prevent their activation, both B cell-intrinsic and extrinsic tolerance mechanisms are in place in healthy individuals. In this review article, I will focus on B cell-intrinsic mechanisms that prevent the activation of autoreactive B cells in the periphery. I will discuss how inhibitory signaling circuits are established in autoreactive B cells, focusing on the Lyn-SHIP-1-SHP-1 axis, how they contribute to peripheral immune tolerance, and how disruptions of these circuits can contribute to the development of autoimmunity.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B cells; autoimmunity; protein kinases/phosphatases; signal transduction; tolerance/suppression/anergy

Mesh:

Substances:

Year:  2022        PMID: 35128676      PMCID: PMC8986582          DOI: 10.1111/imr.13070

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  203 in total

Review 1.  B cell antigen receptor signaling 101.

Authors:  Joseph M Dal Porto; Stephen B Gauld; Kevin T Merrell; David Mills; Aimee E Pugh-Bernard; John Cambier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

2.  B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation.

Authors:  Palash Chandra Maity; Amy Blount; Hassan Jumaa; Olaf Ronneberger; Björn F Lillemeier; Michael Reth
Journal:  Sci Signal       Date:  2015-09-15       Impact factor: 8.192

Review 3.  Clinical significance and immunobiology of IL-21 in autoimmunity.

Authors:  Di Long; Yongjian Chen; Haijing Wu; Ming Zhao; Qianjin Lu
Journal:  J Autoimmun       Date:  2019-02-14       Impact factor: 7.094

4.  What goes up must come down: A tripartite Dok-3/Grb2/SHIP1 inhibitory module limits BCR signaling.

Authors:  Michael Reth; Michael R Gold
Journal:  Eur J Immunol       Date:  2016-11       Impact factor: 5.532

5.  Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosis.

Authors:  Konstantinos Melissaropoulos; Stamatis-Nick Liossis
Journal:  Rheumatol Int       Date:  2018-06-04       Impact factor: 2.631

6.  Silencing of high-affinity insulin-reactive B lymphocytes by anergy and impact of the NOD genetic background in mice.

Authors:  Mia J Smith; Rochelle M Hinman; Andrew Getahun; Soojin Kim; Thomas A Packard; John C Cambier
Journal:  Diabetologia       Date:  2018-09-25       Impact factor: 10.122

7.  B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.

Authors:  Andrew C Vendel; Jill Calemine-Fenaux; Anita Izrael-Tomasevic; Vandana Chauhan; David Arnott; Dan L Eaton
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

8.  B cell-specific loss of Lyn kinase leads to autoimmunity.

Authors:  Chrystelle Lamagna; Yongmei Hu; Anthony L DeFranco; Clifford A Lowell
Journal:  J Immunol       Date:  2013-12-27       Impact factor: 5.422

9.  Self-tolerance curtails the B cell repertoire to microbial epitopes.

Authors:  Akiko Watanabe; Kuei-Ying Su; Masayuki Kuraoka; Guang Yang; Alexander E Reynolds; Aaron G Schmidt; Stephen C Harrison; Barton F Haynes; E William St Clair; Garnett Kelsoe
Journal:  JCI Insight       Date:  2019-05-16

10.  Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity.

Authors:  Margaret L Hibbs; Kenneth W Harder; Jane Armes; Nicole Kountouri; Cathy Quilici; Franca Casagranda; Ashley R Dunn; David M Tarlinton
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more
  2 in total

1.  Many Achilles' heels of B and T cell tolerance.

Authors:  Roberta Pelanda; Julie Zikherman
Journal:  Immunol Rev       Date:  2022-03-18       Impact factor: 12.988

2.  Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.

Authors:  Maya Sangesland; Alba Torrents de la Peña; Seyhan Boyoglu-Barnum; Larance Ronsard; Faez Amokrane Nait Mohamed; Thalia Bracamonte Moreno; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Musie Ghebremichael; Masaru Kanekiyo; Andrew Ward; Daniel Lingwood
Journal:  Immunity       Date:  2022-08-10       Impact factor: 43.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.